Evaxion A (EVAX) Cash & Equivalents Growth (1y) (2020 - 2026)
Evaxion A (EVAX) Cash & Equivalents Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 988.88% |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -68.22% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 4.77% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 3.35% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 269.98% |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 17.50% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -4.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.35% |
| Dec 31, 2025 | 290.36% |
| Jun 30, 2025 | 84.49% |
| Mar 31, 2025 | 152,001.27% |
| Dec 31, 2024 | 6.61% |
| Jun 30, 2024 | 12.29% |
| Mar 31, 2024 | -99.89% |
| Dec 31, 2023 | -57.65% |
| Sep 30, 2023 | -85.41% |
| Jun 30, 2023 | -71.81% |
| Mar 31, 2023 | -67.40% |
| Dec 31, 2022 | -59.01% |
| Sep 30, 2022 | 49.47% |
| Jun 30, 2022 | 34.33% |
| Mar 31, 2022 | 16.52% |
| Dec 31, 2021 | 451.35% |
| Dec 31, 2020 | -38.97% |